stocks logo

TERN Valuation

Terns Pharmaceuticals Inc
$
3.010
-0.290(-8.790%)
  • Overview
  • Forecast
  • Valuation

TERN Relative Valuation

TERN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TERN is overvalued; if below, it's undervalued.

Historical Valuation

P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.83
P/B
Median3y
1.51
Median5y
1.40
-22.93
FCF Yield
Median3y
-22.68
Median5y
-22.98

Competitors Valuation Multiple

The average P/S ratio for TERN's competitors is 7.49, providing a benchmark for relative valuation. Terns Pharmaceuticals Inc Corp (TERN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
Revenue Growth
Market Cap
stocks logo
TERN.O
Terns Pharmaceuticals Inc
Loss
Average P/S: 7.49
262.88M
stocks logo
GLUE.O
Monte Rosa Therapeutics Inc
5.71
254.34M
stocks logo
AURA.O
Aura Biosciences Inc
Loss
274.97M
stocks logo
IVA.O
Inventiva SA
32.23
330.34M
stocks logo
DRUG.O
Bright Minds Biosciences Inc
Loss
204.42M
stocks logo
MXCT.O
MaxCyte Inc
7.03
-44.51%
282.81M

People Also Watch

stocks logo
QTRX
Quanterix Corp
5.350
USD
-7.92%
stocks logo
LWAY
Lifeway Foods Inc
23.270
USD
-0.34%
stocks logo
NEWT
NewtekOne Inc
9.540
USD
-3.05%
stocks logo
BARK
Bark Inc
1.120
USD
0.00%
stocks logo
KLTR
Kaltura Inc
2.210
USD
-0.45%
stocks logo
TBRG
TruBridge Inc
25.460
USD
-3.16%
stocks logo
GLUE
Monte Rosa Therapeutics Inc
4.135
USD
-10.69%
stocks logo
PMTS
CPI Card Group Inc
25.340
USD
-2.99%
stocks logo
ABSI
Absci Corp
2.650
USD
-7.67%
stocks logo
ACNB
ACNB Corp
42.670
USD
+0.40%

FAQ

arrow icon

Is Terns Pharmaceuticals Inc (TERN) currently overvalued or undervalued?

Terns Pharmaceuticals Inc (TERN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 11.88. The fair price of Terns Pharmaceuticals Inc (TERN) is between to according to relative valuation methord.
arrow icon

What is Terns Pharmaceuticals Inc (TERN) fair value?

arrow icon

How does TERN's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Terns Pharmaceuticals Inc (TERN) as of May 07 2025?

arrow icon

What is the current FCF Yield for Terns Pharmaceuticals Inc (TERN) as of May 07 2025?

arrow icon

What is the current Forward P/E ratio for Terns Pharmaceuticals Inc (TERN) as of May 07 2025?

arrow icon

What is the current Forward P/S ratio for Terns Pharmaceuticals Inc (TERN) as of May 07 2025?